Related Experiment Video
Updated: Oct 16, 2026

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat
Published on: October 6, 2018
Cancer pain management with concurrent complex gastrointestinal pathology: A case for sublingual buprenorphine
Courtney Campbell1, Ryan Baldeo2
1Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix, Arizona. ORCID: https://orcid.org/0009-0007-6227-1964.
Abstract:
A 35-year-old male with a complex gastrointestinal history and metastatic intrahepatic cholangiocarcinoma was hospitalized with intractable cancer-associated pain, unrelieved by oral opioids at escalating doses. Transdermal options were contraindicated due to ozone bath therapy. Given the poor response to previous opioid trials and concerns regarding oral absorption, sublingual buprenorphine was initiated, leading to significant improvement in functional pain control. Despite recurrent malignant bowel obstructions with intolerance to oral intake, the patient consistently maintained tolerable pain control until discharge to hospice services. This case highlights sublingual buprenorphine as an effective strategy for complex cancer pain in patients with limited analgesic routes.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs for Treatment of Constipation-Predominant IBS